Amantadine monotherapy of chronic hepatitis C patients infected with genotype 1b

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 5, 2000, Pages 575-576

  Senturk, H ^a   Mert, A ^a   Akdogan, M ^b   Tabak, F ^a   Basaran, G ^a   Turkoglu, S ^c   Ozbay, G ^a   Badur, S ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; CHRONIC PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MALE; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0033790649     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655400458965     Document Type: Article

References (7)

1. Treatment of chronic hepatitis C with amantadine
2. Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients
3. A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy
4. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
5. A second generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced form the core
6. Prophylaxis and treatment of influenza
7. Long-term efficacy of Interferon-α and Ursodeoxycholic acid in the treatment of chronic type C hepatitis